Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

FDA Approves Seattle Genetics' Adcetris to Treat Disfiguring Blood Cancer

biospaceNovember 10, 2017

Tag: blood cancer , ADCETRIS

PharmaSources Customer Service